Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults (Q34634002)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

Plasmodium falciparum

0 references

0 references

1 reference

based on heuristic

inferred from title

Plasmodium falciparum malaria

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

14

1 reference

Europe PubMed Central

3 August 2017

Alexandra Spencer

15

object named as

Alexandra J Spencer

1 reference

Europe PubMed Central

3 August 2017

Katharine A Collins

object named as

Katharine A Collins

8

0 references

Egeruan B Imoukhuede

object named as

Egeruan B Imoukhuede

26

0 references

Muhammed Afolabi

object named as

Muhammed Afolabi

2

0 references

object named as

Joseph Okebe

18

0 references

object named as

Britta C Urban

28

0 references

Kalifa A Bojang

object named as

Kalifa Bojang

33

0 references

Caroline Ogwang

object named as

Caroline Ogwang

1

0 references

27

object named as

Philip Bejon

1 reference

Europe PubMed Central

3 August 2017

Adrian V. S. Hill

32

object named as

Adrian V S Hill

1 reference

Europe PubMed Central

3 August 2017

31

object named as

Roma Chilengi

1 reference

Europe PubMed Central

3 August 2017

30

object named as

Katie J Ewer

1 reference

Europe PubMed Central

3 August 2017

Alison M. Lawrie

24

object named as

Alison M Lawrie

1 reference

Europe PubMed Central

3 August 2017

12

object named as

Eleanor Berrie

1 reference

Europe PubMed Central

3 August 2017

Susanne H. Sheehy

5

object named as

Susanne H Sheehy

1 reference

Europe PubMed Central

3 August 2017

6

object named as

Carly M Bliss

1 reference

Europe PubMed Central

3 August 2017

Nicola K. Viebig

21

object named as

Nicola K Viebig

1 reference

Europe PubMed Central

3 August 2017

3

object named as

Domtila Kimani

1 reference

Europe PubMed Central

3 August 2017

Nicholas A Anagnostou

11

object named as

Nicholas A Anagnostou

1 reference

Europe PubMed Central

3 August 2017

Stefano Colloca

19

object named as

Stefano Colloca

1 reference

Europe PubMed Central

3 August 2017

Alfredo Nicosia

25

object named as

Alfredo Nicosia

1 reference

Europe PubMed Central

3 August 2017

Katherine Gantlett

23

object named as

Katherine Gantlett

1 reference

Europe PubMed Central

3 August 2017

Ya Jankey Jagne

4

object named as

Ya Jankey Jagne

1 reference

Europe PubMed Central

3 August 2017

10

object named as

Eva Kimani

1 reference

Europe PubMed Central

3 August 2017

16

object named as

Peninah Soipei

1 reference

Europe PubMed Central

3 August 2017

Katie L Flanagan

29

object named as

Katie L Flanagan

1 reference

Europe PubMed Central

3 August 2017

Miguel A Garcia-Knight

9

object named as

Miguel A Garcia Knight

1 reference

Europe PubMed Central

3 August 2017

author name string

Christopher J A Duncan

7

1 reference

Europe PubMed Central

3 August 2017

Sarah Moyle

13

1 reference

Europe PubMed Central

3 August 2017

Jenny Mueller

17

1 reference

Europe PubMed Central

3 August 2017

Riccardo Cortese

20

1 reference

Europe PubMed Central

3 August 2017

Rachel Roberts

22

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

19 March 2013

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

3

1 reference

Europe PubMed Central

3 August 2017

e57726

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

19 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Global malaria mortality between 1980 and 2010: a systematic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Vaccines against malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Protective immunity to pre-erythrocytic stage malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Immunological correlates of protection for the RTS,S candidate malaria vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Continued decline of malaria in The Gambia with implications for elimination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Prime-boost vectored malaria vaccines: progress and prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

From the circumsporozoite protein to the RTS, S/AS candidate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

The decline in paediatric malaria admissions on the coast of Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

A protein particle vaccine containing multiple malaria epitopes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 1. A review of the epidemiology and control of malaria in The Gambia, west Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

7 July 2018

Malaria elimination: worthy, challenging, and just possible.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0057726

21 January 2018

RTS,S/AS01 malaria vaccine in African children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3602521

26 October 2018

Identifiers

10.1371/JOURNAL.PONE.0057726

1 reference

Europe PubMed Central

3 August 2017

2013PLoSO...857726O

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34634002&oldid=2097161806"